Restricted accessResearch articleFirst published online 2025-10
A 51-Year-Old Woman With Subarachnoid Hemorrhage and Secondary Central Nervous System Vasculitis With Progression to Diffuse,Serpiginous Dolichoectasia
A 51-year-old woman presented with acute onset of a severe headache, and was found to have diffuse subarachnoid hemorrhage with prominent cisternal and left cortical convexity blood on head computed tomography. The first 2 conventional angiograms were negative for aneurysm, but a third angiogram revealed a mycotic aneurysm of a distal left middle cerebral artery branch. Brain biopsy, associated with clipping of the aneurysm, demonstrated pathology consistent with vasculitis. Over the course of a month, she developed diffuse, serpiginous dolichoectasia of the cerebral arteries. Further investigation into the cause of vasculitis supported a diagnosis of either eosinophilic granulomatosis with polyangiitis (EGPA) or IgG4-Related Disease (IgG4-RD). The following clinical pathologic conference discusses the diagnostic challenges in discriminating between these 2 diseases, particularly in the setting of secondary angiitis of the central nervous system.
ZimentI. Nervous system complications in bacterial endocarditis. Am J Med. 1969;47:593-607.
4.
SalvaraniCBrownRDJrCalamiaKT, et al.Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol. 2007;62:442-451.
5.
GeschwindMDShuHHamanASejvarJJMillerBL. Rapidly progressive dementia. Ann Neurol. 2008;64:97-108.
6.
SörnäsRÖstlundHMüllerR. Cerebrospinal fluid cytology after stroke. Arch Neurol. 1972;26:489-501.
7.
RundbladLISIversenHKWestAS. Pleocytosis in cerebrospinal fluid attributed to ischemic stroke: a review of the literature. J Neurol Sci. 2023;449:120664.
8.
KoopmanIZuithoffNPARinkelGJEVergouwenMDI. The course of cerebrospinal fluid parameters ≤ 20 days after aneurysmal subarachnoid hemorrhage. J Neurol Sci. 2020;415:116899.
9.
CalabreseLHMallekJA. Primary angiitis of the central nervous system: report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine. 1988;67:20-39.
10.
GiangDW. Central nervous system vasculitis secondary to infections, toxins, and neoplasms. Semin Neurol. 1994;14:313-319.
11.
Soto-HernandezJLAndradeSG-LRojas-EcheverriLATexeiraFRomeroV. Subarachnoid hemorrhage secondary to a ruptured inflammatory aneurysm: a possible manifestation of neurocysticercosis: case report. Neurosurgery. 1996;38:197-200.
12.
JacobiCSchwarkCKressBHugAStorch-HagenlocherBSchwaningerM. Subarachnoid hemorrhage due to Borrelia burgdorferi-associated vasculitis. Eur J Neurol. 2006;13:536-538.
13.
HoCLDeruytterMJ. CNS aspergillosis with mycotic aneurysm, cerebral granuloma and infarction. Acta Neurochir. 2004;146:851-856.
14.
ZhengJZhangJ. Neoplastic cerebral aneurysm from metastatic tumor: a systematic review of clinical and treatment characteristics. Clin Neurol Neurosurg. 2015;128:107-111.
15.
AndaTHaraguchiWMiyazatoH, et al.Ruptured distal middle cerebral artery aneurysm filled with tumor cells in a patient with intravascular large B-cell lymphoma: case report. J Neurosurg. 2008;109:492-496.
16.
ChenLYCMattmanASeidmanMACarruthersMN. IgG4-related disease: what a hematologist needs to know. Haematologica. 2019;104:444-455.
17.
EmmiGBettiolAGelainE, et al.Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol. 2023;19:378-393.
18.
GuillevinLLhoteFGayraudM, et al.Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltim). 1996;75:17-28.
19.
HaiderMHajiFAlalwanOAljufairiEShahTS. IgG4-Related disease, the malignancy mimicker: case series from Bahrain. Case Rep Rheumatol. 2018;2018:4057024.
20.
HegadeVSSheridanMBHuggettMT. Diagnosis and management of IgG4-related disease. Frontline Gastroenterol. 2019;10:275-283.
21.
MoussaddyALevyAStrbianDSundararajanSBertheletFLanthierS. Inflammatory cerebral amyloid angiopathy, amyloid-β–related angiitis, and primary angiitis of the central nervous system. Stroke. 2015;46:e210-e213.
22.
DeshpandeVZenYChanJK, et al.Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181-1192.
23.
YooJSongJJParkY-BLeeS-W. Definite IgG4-related disease had no overlap with eosinophilic granulomatosis with polyangiitis in Korean patients: a pilot study in one centre. Clin Rheumatol. 2020;39:3009-3015.
24.
WuZZhangSSongNZhangFLiY. Elevated serum IgG4 was found in eosinophilic granulomatosis with polyangiitis. J Clin Rheumatol. 2021;27:e501-e504.
25.
VaglioAStrehlJDMangerB, et al.IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis. 2012;71:390-393.
26.
MasiATHunderGGLieJT, et al.The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094-1100.
27.
KhouryPGraysonPCKlionAD. Eosinophils in vasculitis: characteristics and roles in pathogenesis. Nat Rev Rheumatol. 2014;10:474-483.
28.
ChurgJStraussL. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951;27:277-301.
29.
AndréRCottinVSarauxJL, et al.Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): report of 26 patients and review of the literature. Autoimmun Rev. 2017;16:963-969.
30.
De LunaGTerrierBKaminskyP, et al.Central nervous system involvement of granulomatosis with polyangiitis: clinical–radiological presentation distinguishes different outcomes. Rheumatology. 2015;54:424-432.
31.
ToyoshimaYEmuraIUmedaYFujitaNKakitaATakahashiH. Vertebral basilar system dolichoectasia with marked infiltration of IgG4-containing plasma cells: a manifestation of IgG4-related disease?Neuropathology. 2012;32:100-104.
32.
MarlinESDornbosDIkedaDSLehmanNLPowersCJ. IgG4-Related disease: a new etiology underlying diffuse intracranial dilating vasculopathy. World Neurosurg. 2017;107:1048.e15-1048.e20.
33.
ComarmondCPagnouxCKhellafM, et al.Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2013;65:270-281.
34.
VaglioABuzioCZwerinaJ. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art. Allergy. 2013;68:261-273.
35.
Brito-ZerónPRamos-CasalsMBoschXStoneJH. The clinical spectrum of IgG4-related disease. Autoimmun Rev. 2014;13:1203-1210.
36.
Martín-NaresESaavedra-GonzálezVFagundo-SierraR, et al.Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease. Sci Rep. 2021;11:1832.
37.
InoueDYoshidaKYonedaN, et al.IgG4-Related disease: dataset of 235 consecutive patients. Medicine. 2015;94:e680.
38.
UmeharaHOkazakiKKawaS, et al.The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021;31:529-533.
39.
JoshiDJagerRHurelS, et al.Cerebral involvement in IgG4-related disease. Clin Med. 2015;15:130-134.
40.
UsamiTKawashimaSUekiYToyodaTOkitaKMatsukawaN. Early treatment for IgG4-related disease may prevent cognitive impairment caused by cerebral vasculitis: a case report and review of the literature. eNeurologicalSci. 2018;10:45-47.
41.
UkaiK. Two cases of IgG4-related disease accompanied by many cerebral microbleeds and a review of the literature: can IgG4-related disease cause cerebral small vessel vasculitis/vasculopathy?Nagoya J Med Sci. 2021;83:649-654.
42.
RegevKNussbaumTCagnanoEGiladiNKarniA. Central nervous system manifestation of IgG4-related disease. JAMA Neurol. 2014;71:767-770.
